MENU
+Compare
KMDA
Stock ticker: NASDAQ
AS OF
Nov 19, 12:03 PM (EDT)
Price
$6.93
Change
+$0.09 (+1.32%)
Capitalization
398.21M

KMDA Kamada Ltd Forecast, Technical & Fundamental Analysis

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company... Show more

Industry: #Biotechnology
KMDA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for KMDA with price predictions
Nov 18, 2025

KMDA in downward trend: price dove below 50-day moving average on November 17, 2025

KMDA moved below its 50-day moving average on November 17, 2025 date and that indicates a change from an upward trend to a downward trend. In of 43 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 50 cases where KMDA's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The 50-day moving average for KMDA moved below the 200-day moving average on October 17, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where KMDA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

KMDA broke above its upper Bollinger Band on November 12, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for KMDA entered a downward trend on October 16, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 18, 2025. You may want to consider a long position or call options on KMDA as a result. In of 97 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for KMDA just turned positive on November 10, 2025. Looking at past instances where KMDA's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .

The 10-day moving average for KMDA crossed bullishly above the 50-day moving average on November 13, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where KMDA advanced for three days, in of 239 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. KMDA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.483) is normal, around the industry mean (18.491). P/E Ratio (19.543) is within average values for comparable stocks, (71.901). Projected Growth (PEG Ratio) (0.649) is also within normal values, averaging (1.834). KMDA has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.030). P/S Ratio (2.288) is also within normal values, averaging (55.234).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. KMDA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
KMDA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

KMDA is expected to report earnings to fall 65.52% to 10 cents per share on March 18

Kamada Ltd KMDA Stock Earnings Reports
Q4'25
Est.
$0.10
Q3'25
Beat
by $0.20
Q2'25
Beat
by $0.11
Q1'25
Est.
$0.07
Q4'24
Beat
by $0.02
The last earnings report on November 10 showed earnings per share of 28 cents, beating the estimate of 9 cents. With 14.85K shares outstanding, the current market capitalization sits at 398.21M.
A.I. Advisor
published General Information

General Information

a company, which engages in pharmaceutical business

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
Biotechnology
Address
2 Holzman Street
Phone
+972 89406472
Employees
378
Web
https://www.kamada.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FGSAX61.940.07
+0.11%
Federated Hermes MDT Mid Cap Growth A
RYCCX485.39N/A
N/A
Rydex NASDAQ-100® 2x Strategy C
AFCNX18.55N/A
N/A
American Century Focused Intl Gr Inv
PETGX13.75N/A
N/A
Gabelli Pet Parents'™ A
BRWJX28.51-0.32
-1.11%
MFS Blended Research Growth Eq I

KMDA and Stocks

Correlation & Price change

A.I.dvisor tells us that KMDA and OGI have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KMDA and OGI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KMDA
1D Price
Change %
KMDA100%
-0.39%
OGI - KMDA
29%
Poorly correlated
+5.03%
SGIOY - KMDA
27%
Poorly correlated
+1.17%
SIGA - KMDA
26%
Poorly correlated
+1.19%
CRDL - KMDA
25%
Poorly correlated
+5.10%
TEVA - KMDA
24%
Poorly correlated
+1.02%
More

Groups containing KMDA

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KMDA
1D Price
Change %
KMDA100%
-0.39%
Pharmaceuticals: Generic
industry (214 stocks)
28%
Poorly correlated
-0.12%